Page last updated: 2024-08-26

bosentan anhydrous and Diabetes Mellitus

bosentan anhydrous has been researched along with Diabetes Mellitus in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dumont, AS; Dumont, RJ; Kassell, NF; McNeill, JH; Sutherland, GR; Verma, S	1
Calvert, RC; Khan, MA; Mikhailidis, DP; Morgan, RJ; Mumtaz, FH; Sullivan, ME; Thompson, CS	1
Chen, J; Gu, Y; Lin, F; Lin, S; Yang, H; Zhu, C; Zhu, W	1

Reviews

1 review(s) available for bosentan anhydrous and Diabetes Mellitus

Article	Year
Normal and pathological erectile function: the potential clinical role of endothelin-1 antagonists. Current drug targets, 2000, Volume: 1, Issue:3 Topics: Animals; Antihypertensive Agents; Bosentan; Diabetes Complications; Diabetes Mellitus; Endothelin-1; Erectile Dysfunction; Humans; Hypercholesterolemia; Hypertension; Male; Myocardial Ischemia; Neural Pathways; Nitric Oxide; Penile Erection; Risk Factors; Smoking; Sulfonamides	2000

Article

Year

Normal and pathological erectile function: the potential clinical role of endothelin-1 antagonists.

Current drug targets, 2000, Volume: 1, Issue:3

Topics: Animals; Antihypertensive Agents; Bosentan; Diabetes Complications; Diabetes Mellitus; Endothelin-1; Erectile Dysfunction; Humans; Hypercholesterolemia; Hypertension; Male; Myocardial Ischemia; Neural Pathways; Nitric Oxide; Penile Erection; Risk Factors; Smoking; Sulfonamides

2000

Other Studies

2 other study(ies) available for bosentan anhydrous and Diabetes Mellitus

Article	Year
Chronic endothelin antagonism restores cerebrovascular function in diabetes. Neurosurgery, 2003, Volume: 52, Issue:3 Topics: Animals; Antihypertensive Agents; Bosentan; Cerebrovascular Disorders; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelium, Vascular; Male; Middle Cerebral Artery; Muscle Development; Potassium Channels; Rats; Rats, Wistar; Receptors, Endothelin; Recovery of Function; Sulfonamides; Vasodilation	2003
[The effects of endothelin blockade on renal expression of angiotensin II type 1 receptor in diabetic hypertensive rats]. Zhonghua yi xue za zhi, 2002, Jan-10, Volume: 82, Issue:1 Topics: Amlodipine; Animals; Antihypertensive Agents; Bosentan; Cilazapril; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Drug Therapy, Combination; Endothelin Receptor Antagonists; Endothelins; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sulfonamides	2002

Article

Year

Chronic endothelin antagonism restores cerebrovascular function in diabetes.

Neurosurgery, 2003, Volume: 52, Issue:3

Topics: Animals; Antihypertensive Agents; Bosentan; Cerebrovascular Disorders; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelium, Vascular; Male; Middle Cerebral Artery; Muscle Development; Potassium Channels; Rats; Rats, Wistar; Receptors, Endothelin; Recovery of Function; Sulfonamides; Vasodilation

2003

[The effects of endothelin blockade on renal expression of angiotensin II type 1 receptor in diabetic hypertensive rats].

Zhonghua yi xue za zhi, 2002, Jan-10, Volume: 82, Issue:1

Topics: Amlodipine; Animals; Antihypertensive Agents; Bosentan; Cilazapril; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Drug Therapy, Combination; Endothelin Receptor Antagonists; Endothelins; Hypertension; Kidney; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sulfonamides

2002